Jon Garinn

Several meetings in early 2013 prepare to focus on young people with cancer.

TreatmentDiaries.com becomes a private website for patients and caregivers to share support and advice.

Ponatinib continues to make improvements in phase 2 CML study.

Velcade-based therapy shows benefit in multiple myeloma trial called GIMEMA.

Telling Kids About Cancer

The Joining FORCES Against Hereditary Cancer Conference

Websites help consumers identify actinic keratosis.

A new drug regimen that combines Treanda (bendamustine) and Rituxan (rituximab) has been shown to more than double progression-free survival time.

Patients who experience chemotherapy-induced peripheral neuropathy may find relief with the antidepressant Cymbalta.

Men with metastatic prostate cancer lived longer with continuous hormone therapy compared with intermittent therapy.

National conference focuses on balancing work and cancer treatment.

Lance Armstrong Foundation launches cancer guide and treatment app.